Finch Therapeutics Gr reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Finch Therapeutics Gr using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-23 | $-16.80 | $-10.20 | -64.7 % |
Q3 | 2022-11-10 | $-13.50 | $-12.00 | -12.5 % |
Q4 | 2022-03-31 | $-12.00 | $-9.60 | -25.0 % |
Q3 | 2021-11-10 | $-6.30 | $-12.60 | 50.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-23 | $8.00K | $400.00K | -98.0 % |
Q3 | 2022-11-10 | $138.00K | $750.00K | -81.6 % |
Finch Therapeutics Gr (FNCH) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2.
Finch Therapeutics Gr (FNCH) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2 and the Actual EPS was $-3.01, which missed the estimate of $0.00.
Finch Therapeutics Gr (FNCH) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 13, 2024 for Q2 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.